|
|
| May 10, 2006: Percutaneous Treatment of AAAs: Who, Why, When, and How |
This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Predicted Aneurysm Rupture: 5 Yrs Post Screening
* Surgical Aneurysm Repair
* Elective Aneurysm Repair Operative Mortality 30-day U.S. Data
* Operative Repair: Non-ruptured AAA
* Open Repair of AAA
* Endoluminal Stent Grafting
* ANCURE Clinical Performance: 4 yrs
* Endoluminal Stent Grafting Conduit Access
* ANCURE Endoluminal Graft
* AneuRx Stent Graft
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
n/a
n/a
|
| |